Showing results (281-290 of 386) with videos related to
Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Survival and late mortality in long-term survivors of pediatric CNS tumorsE Brannon Morris, Amar Gajjar, James O Okuma, et al.Cancer|March 15, 1993
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcomaA S Pappo, E Etcubanas, V M Santana, et al.Lancet (London, England)|August 18, 1990
Myeloid neoplasia in children treated for solid tumoursC H Pui, M L Hancock, S C Raimondi, et al.Blood|June 8, 2013
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiationKevin R Krull, Nan Zhang, Aimee Santucci, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's diseaseSwati K Basu, Cindy Schwartz, Susan G Fisher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004)Sridharan Gururangan, William P Petros, Tina Young Poussaint, et al.The Journal of Pediatrics|August 4, 1999
Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonistR H Lustig, S R Rose, G A Burghen, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 1999
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapyL R Mandell, R Kadota, C Freeman, et al.International Journal of Radiation Oncology, Biology, Physics|September 26, 2007
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastomaThomas E Merchant, Larry E Kun, Matthew J Krasin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012Tobey J MacDonald, Clinton F Stewart, Mehmet Kocak, et al.Pageof 39